Urinalysis Market

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027

Report Code: MD 3259 Feb, 2023, by marketsandmarkets.com

Updated on : May 02, 2023

The global urinalysis market in terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.7 billion by 2027, growing at a CAGR of 8.1% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is driven by the increased focus of government on disease screening, high prevalence of life style related diseases like diabetes and kidney disease and increasing initiatives to spread the awareness on diabetes and related diseases.

Urinalysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

Urinalysis Market Dynamics

Driver: Increasing burden of UTIs, diabetes and liver & kidney diseases

There is a widespread application of urinalysis in the diagnosis and management of diseases like kidney and liver diseases. Urinalysis enables clinicians to assess the level of chemical compounds in the urine. These factors will drive the market growth.

Opportunity: Emerging market

the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in emerging countries play an essential role in upgrading laboratory infrastructure.

Restraint: Availability of refurbished urine analyzers

In developing countries, which are price-sensitive, prefer instruments that are cheap and offer similar functionalities. In the absence of well-grounded regulatory frameworks, there may be an influx of low-quality and refurbished products into the economy. These devilow cost analyzers will hamper the market growth.

Challenge: Changing regulatory landscape for the urinalysis market

Regulatory and legal requirements applied to IVD (including urinalysis) in the US and European countries are becoming more stringent. New applications may be required for software updates or new software installation in an existing device or any other changes made to these devices. Which is a major challenge in the growth of this market.

Consumables segment accounted for the largest share of the urinalysis market, by product

The market is segmented into consumables and instruments. The consumables segment accounted for the largest share of the market, mainly due to the rising investment for development of new diagnostic products, increasing providers awareness about rapid and novel diagnostic technologies and increased need of rapid disease diagnosis.

Pregnancy & fertility tests segment accounted for the largest share of the urinalysis market, by test type

The market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. The pregnancy & fertility tests segment accounted for the largest share of the market, mainly due to the technological advancements in the diagnostic products.

Disease screening segment accounted for the largest share of the urinalysis market, by application

The market is segmented into disease screening and pregnancy & fertility. The disease screening segment accounted for the largest share of the market, mainly due to the rising geriatric population and age related diseases, emerging economies providing significant growth opportunities and increased adoption of POC diagnosis which largely includes urinalysis for rapid and convenient results.

Diagnostic laboratories segment accounted for the largest share of the urinalysis market, by end user

The market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. The diagnostic laboratories segment accounted for the largest share. Factors such as increased age related diseases and increased use of POC analyzers, favorble regulatory guidelines & reimbursement scenarios in the developed countries like North America and Europe .

North America is the largest regional market for urinalysis market

The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global market. The North American market's growth can be attributed to the increase in diseases like diabetes and UTIs, supportive government policies and high investment for the development and approval of diagnostic tests for preventice care.

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (US), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (UK), Alphatech Scientitfic (Peru), Teco Diagnostics (US), Analyticon Technologies AG (Germany), Bioway Biological Technology Co. Ltd. (China), High Technology Inc. (US) and Agappe Diagnostics Ltd. (India)

Urinalysis Market Report Scope

Report Metric

Details

Market Revenue in 2022

$3.9 billion

Projected Revenue by 2027

$5.7 billion

Revenue Rate

Poised to grow at a CAGR of 8.1%

Market Driver

Increasing burden of UTIs, diabetes and liver & kidney diseases

Market Opportunity

Emerging market

This report categorizes the global urinalysis market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Consumables
  • Instruments

By Test Type

  • Pregnancy & Fertility Tests
  • Biochemical Urinalysis
  • Sediment Urinalysis

By Application

  • Disease Screening
  • Pregnancy and Fertility

By End User

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Home Care Settings
  • Research Laboratories & Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Recent Developments:

  • In September 2022, Sysmex Corporation (Japan) launched the UF-1500 fully automated urine particle analyzer, a Product for the urine sediment testing field.
  • In February 2021, Thermo Fisher Scientific, Inc. (US) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) signed an agreement to offer the FDA-cleared and Health Canada–approved BS-480 (400 tests/hour) and BA-800M (800 tests/hour) analyzers to toxicology labs.
  • In August 2020, Sysmex America, Inc. (a subsidiary of Sysmex Corporation) and Siemens Healthineers AG (Germany) announced an exclusive agreement.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 31)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKETS COVERED 
           1.3.1 URINALYSIS MARKET SEGMENTATION
           1.3.2 REGIONAL SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA 
    2.2 RESEARCH APPROACH 
          FIGURE 1 URINALYSIS MARKET SIZE: RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
                    2.2.1.2 Activities involved in secondary research
           2.2.2 PRIMARY DATA
                    2.2.2.1 Primary sources
                    2.2.2.2 Key data from primary sources
                    2.2.2.3 Key industry insights
                    2.2.2.4 Breakdown of primary interviews
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Approach 1: Company revenue estimation
                                FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.3.1.2 Approach 2: Company presentations and primary interviews
                    2.3.1.3 CAGR projections
                                FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 6 URINALYSIS TEST MARKET: TOP-DOWN APPROACH
    2.4 DATA TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ANALYSIS 
    2.6 STUDY ASSUMPTIONS 
    2.7 GROWTH RATE ASSUMPTIONS 
    2.8 RISK ASSESSMENT 
           2.8.1 RISK ASSESSMENT: MARKET
    2.9 RECESSION IMPACT 
 
3 EXECUTIVE SUMMARY (Page No. - 49)
    FIGURE 8 URINALYSIS MARKET SIZE, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 URINALYSIS TEST MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 URINALYSIS INDUSTRY, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 URINALYSIS TEST MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
 
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 URINALYSIS MARKET OVERVIEW 
          FIGURE 13 RISING ADOPTION OF POC DIAGNOSTICS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
    4.2 MARKET SHARE, BY PRODUCT, 2022 VS. 2027 
          FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.3 MARKET SHARE, BY TEST TYPE, 2022 VS. 2027 
          FIGURE 15 BIOCHEMICAL URINALYSIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
    4.4 URINALYSIS TEST MARKET SHARE, BY APPLICATION, 2022 VS. 2027 
          FIGURE 16 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
    4.5 URINALYSIS MARKET SHARE, BY END USER, 2022 VS. 2027 
          FIGURE 17 DIAGNOSTICS LABORATORIES TO ACCOUNT FOR DOMINANT MARKET SHARE DURING FORECAST PERIOD
    4.6 MARKET: REGIONAL GROWTH OPPORTUNITIES 
          FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 URINALYSIS MARKET SIZE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases to impact market
                    5.2.1.2 Rising geriatric population and age-associated diseases to fuel market growth
                                TABLE 1 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050)
                    5.2.1.3 Increasing adoption of POC urine diagnostic tests to drive market
           5.2.2 RESTRAINTS
                    5.2.2.1 Availability of refurbished urine analyzers to pose challenges for market
                    5.2.2.2 High capital investments and lack of skilled laboratory technicians to restrain market growth
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing investments in healthcare and life sciences to fuel growth in emerging markets
                    5.2.3.2 Technological advancements in urine analyzers to augment market growth
                    5.2.3.3 Increasing government initiatives and funding for preventive care to provide growth opportunities
           5.2.4 CHALLENGES
                    5.2.4.1 Changing regulatory landscape to challenge market growth
 
6 URINALYSIS MARKET SIZE, BY PRODUCT (Page No. - 61)
    6.1 INTRODUCTION 
             TABLE 2 URINALYSIS TEST MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 CONSUMABLES 
             TABLE 3 MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 4 MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION)
           6.2.1 PREGNANCY & FERTILITY KITS
                    6.2.1.1 Rapid accessibility and testing convenience to drive market
                                TABLE 5 MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2020–2027 (USD MILLION)
           6.2.2 DIPSTICKS
                    6.2.2.1 Low cost and standard efficiency to increase use of dipsticks
                                TABLE 6 MARKET FOR DIPSTICKS, BY REGION, 2020–2027 (USD MILLION)
           6.2.3 DISPOSABLES
                    6.2.3.1 Urine collection cups to drive demand for disposables
                                TABLE 7 URINALYSIS INDUSTRY FOR DISPOSABLES, BY REGION, 2020–2027 (USD MILLION)
           6.2.4 REAGENTS
                    6.2.4.1 Increasing use of controls and calibrators to drive market growth
                                TABLE 8 MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION)
    6.3 INSTRUMENTS 
             TABLE 9 KEY PRODUCTS IN INSTRUMENTS SEGMENT
             TABLE 10 MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 11 MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION)
           6.3.1 AUTOMATED URINE ANALYZERS
                    TABLE 12 MARKET FOR AUTOMATED URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 13 MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
                    6.3.1.1 Integrated urine analyzers
                               6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
                                              TABLE 14 MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
                    6.3.1.2 Sediment urine analyzers
                                TABLE 15 MARKET FOR SEDIMENT URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 16 MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
                               6.3.1.2.1 Microscopy analyzers
                                             6.3.1.2.1.1 Increased adoption of automated microscopy urine analyzers to drive market growth
                                                              TABLE 17 MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
                               6.3.1.2.2 Flow cytometry analyzers
                                             6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
                                                              TABLE 18 MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
                    6.3.1.3 Biochemical urine analyzers
                               6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
                                              TABLE 19 MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 SEMI-AUTOMATED URINE ANALYZERS
                    6.3.2.1 Extensive use of semi-automated urine analyzers in hospitals & clinics to drive segment growth
                                TABLE 20 MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
           6.3.3 POINT-OF-CARE URINE ANALYZERS
                    6.3.3.1 Need for rapid testing to drive demand for POC urine analyzers
                                TABLE 21 MARKET FOR POC URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)
 
7 URINALYSIS MARKET SIZE, BY TEST TYPE (Page No. - 76)
    7.1 INTRODUCTION 
             TABLE 22 URINALYSIS TEST MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
    7.2 PREGNANCY & FERTILITY TESTS 
           7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE SEGMENT GROWTH
                    TABLE 23 MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2020–2027 (USD MILLION)
    7.3 BIOCHEMICAL TESTS 
             TABLE 24 MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 25 MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2020–2027 (USD MILLION)
           7.3.1 LABORATORY TESTS
                    7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
                                TABLE 26 URINALYSIS INDUSTRY FOR LABORATORY TESTS, BY REGION, 2020–2027 (USD MILLION)
           7.3.2 POC TESTS
                    7.3.2.1 Convenience of POC testing to drive segment growth
                                TABLE 27 MARKET FOR POC TESTS, BY REGION, 2020–2027 (USD MILLION)
    7.4 SEDIMENT URINALYSIS 
           7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET GROWTH
                    TABLE 28 MARKET FOR SEDIMENT URINALYSIS, BY TYPE, 2020–2027 (USD MILLION)
 
8 URINALYSIS MARKET SHARE, BY APPLICATION (Page No. - 82)
    8.1 INTRODUCTION 
             TABLE 29 URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 DISEASE SCREENING 
             TABLE 30 MARKET FOR DISEASE SCREENING, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 31 MARKET FOR DISEASE SCREENING, BY REGION, 2020–2027 (USD MILLION)
           8.2.1 URINARY TRACT INFECTIONS
                    8.2.1.1 Increasing prevalence of UTIs to drive segment growth
                                TABLE 32 MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020–2027 (USD MILLION)
           8.2.2 KIDNEY DISEASES
                    8.2.2.1 Rapidly growing geriatric population and prevalence of kidney diseases to fuel segment growth
                                TABLE 33 URINALYSIS INDUSTRY FOR KIDNEY DISEASES, BY REGION, 2020–2027 (USD MILLION)
           8.2.3 DIABETES
                    8.2.3.1 Development of advanced analytical tools for diabetes to drive market growth
                                TABLE 34 MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)
           8.2.4 LIVER DISEASES
                    8.2.4.1 High prevalence of liver diseases to fuel segment growth
                                TABLE 35 MARKET FOR LIVER DISEASES, BY REGION, 2020–2027 (USD MILLION)
           8.2.5 OTHER DISEASE SCREENING APPLICATIONS
                    TABLE 36 MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
    8.3 PREGNANCY & FERTILITY 
           8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
                    TABLE 37 MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2020–2027 (USD MILLION)
 
9 URINALYSIS MARKET SHARE, BY END USER (Page No. - 90)
    9.1 INTRODUCTION 
          TABLE 38 URINALYSIS TEST MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 DIAGNOSTIC LABORATORIES 
           9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
                    TABLE 39 URINALYSIS INDUSTRY FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
    9.3 HOSPITALS & CLINICS 
           9.3.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE MARKET
                    TABLE 40 MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)
    9.4 HOME CARE SETTINGS 
           9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
                    TABLE 41 MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
    9.5 RESEARCH LABORATORIES & INSTITUTES 
           9.5.1 DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
                    TABLE 42 MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
 
10 URINALYSIS MARKET SHARE, BY REGION (Page No. - 96)
     10.1 INTRODUCTION 
             TABLE 43 URINALYSIS MARKET PREDICTION, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 20 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
             TABLE 44 NORTH AMERICA: URINALYSIS INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 45 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 46 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 47 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 48 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 49 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 50 NORTH AMERICA: URINALYSIS MARKET PREDICTION, BY TEST TYPE, 2020–2027 (USD MILLION)
             TABLE 51 NORTH AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 52 NORTH AMERICA: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 53 NORTH AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 54 NORTH AMERICA: URINALYSIS MARKET SHARE, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 RECESSION IMPACT
             10.2.2 US
                        10.2.2.1 Rapid growth of geriatric population to drive market growth
                                      TABLE 55 US: URINALYSIS MARKET SHARE, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 56 US: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 57 US: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 58 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 59 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 60 US: URINALYSIS MARKET PREDICTION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 61 US: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 62 US: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 63 US: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 64 US: URINALYSIS MARKET FORECAST, BY END USER, 2020–2027 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Increasing prevalence of chronic diseases to augment market
                                      TABLE 65 CANADA: URINALYSIS MARKET FORECAST, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 66 CANADA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 67 CANADA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 68 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 69 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 70 CANADA: URINALYSIS MARKET PREDICTION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 71 CANADA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 72 CANADA: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 73 CANADA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 74 CANADA: URINALYSIS MARKET FORECAST, BY END USER, 2020–2027 (USD MILLION)
     10.3 EUROPE 
             TABLE 75 EUROPE: URINALYSIS MARKET FORECAST, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 76 EUROPE: URINALYSIS INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 77 EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 78 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 79 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 80 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 81 EUROPE: URINALYSIS MARKET PREDICTION, BY TEST TYPE, 2020–2027 (USD MILLION)
             TABLE 82 EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 83 EUROPE: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 84 EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 85 EUROPE: URINALYSIS MARKET FORECAST, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 RECESSION IMPACT
             10.3.2 GERMANY
                        10.3.2.1 Increasing healthcare expenditure to fuel market growth
                                      TABLE 86 GERMANY: URINALYSIS MARKET TRENDS, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 87 GERMANY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 88 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 89 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 90 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 91 GERMANY: URINALYSIS MARKET SEGMENTATION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 92 GERMANY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 93 GERMANY: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 94 GERMANY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 95 GERMANY: URINALYSIS MARKET TRENDS, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Rising government healthcare expenditure to propel market growth
                                      TABLE 96 UK: URINALYSIS MARKET TRENDS, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 97 UK: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 98 UK: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 99 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 100 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 101 UK: URINALYSIS MARKET SEGMENTATION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 102 UK: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 103 UK: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 104 UK: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 105 UK: URINALYSIS MARKET TRENDS, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 High R&D expenditure to provide growth opportunities
                                      TABLE 106 FRANCE: URINALYSIS MARKET TRENDS, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 107 FRANCE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 108 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 109 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 110 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 111 FRANCE: URINALYSIS MARKET SEGMENTATION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 112 FRANCE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 113 FRANCE: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 114 FRANCE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 115 FRANCE: URINALYSIS MARKET OVERVIEW, BY END USER, 2020–2027 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Large aging population to drive market growth
                                      TABLE 116 ITALY: URINALYSIS MARKET OVERVIEW, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 117 ITALY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 118 ITALY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 119 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 120 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 121 ITALY: URINALYSIS MARKET SEGMENTATION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 122 ITALY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 ITALY: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 124 ITALY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 125 ITALY: URINALYSIS MARKET OVERVIEW, BY END USER, 2020–2027 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Rising geriatric population to propel market
                                      TABLE 126 SPAIN: URINALYSIS MARKET OVERVIEW, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 127 SPAIN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 128 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 129 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 130 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 131 SPAIN: URINALYSIS MARKET SEGMENTATION, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 132 SPAIN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 133 SPAIN: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 134 SPAIN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 135 SPAIN: URINALYSIS MARKET GROWTH, BY END USER, 2020–2027 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 136 REST OF EUROPE: URINALYSIS MARKET GROWTH, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 137 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 138 REST OF EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 139 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 140 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 141 REST OF EUROPE: URINALYSIS MARKET SEGMENTS, BY TEST TYPE, 2020–2027 (USD MILLION)
                        TABLE 142 REST OF EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 143 REST OF EUROPE: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 144 REST OF EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 145 REST OF EUROPE: URINALYSIS MARKET GROWTH, BY END USER, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 21 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
             TABLE 146 ASIA PACIFIC: URINALYSIS INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 147 ASIA PACIFIC: URINALYSIS INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 148 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 149 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 150 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 151 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 152 ASIA PACIFIC: URINALYSIS MARKET SEGMENTS, BY TEST TYPE, 2020–2027 (USD MILLION)
             TABLE 153 ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 154 ASIA PACIFIC: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 155 ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 156 ASIA PACIFIC: URINALYSIS MARKET GROWTH, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 RECESSION IMPACT
             10.4.2 CHINA
                        10.4.2.1 Improving healthcare infrastructure in China to support market growth
                                      TABLE 157 CHINA: URINALYSIS MARKET GROWTH, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 158 CHINA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 159 CHINA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 160 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 161 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 162 CHINA: URINALYSIS MARKET SEGMENTS, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 163 CHINA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 164 CHINA: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 165 CHINA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 166 CHINA: URINALYSIS MARKET REPORT, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Favorable regulatory framework to drive market growth
                                      TABLE 167 JAPAN: URINALYSIS MARKET REPORT, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 168 JAPAN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 169 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 170 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 171 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 172 JAPAN: URINALYSIS MARKET SEGMENTS, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 173 JAPAN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 174 JAPAN: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 175 JAPAN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 176 JAPAN: URINALYSIS MARKET REPORT, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Increasing investment in India’s healthcare system to drive market
                                      TABLE 177 INDIA: URINALYSIS MARKET REPORT, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 178 INDIA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 179 INDIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 181 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 182 INDIA: URINALYSIS MARKET SEGMENTS, BY TEST TYPE, 2020–2027 (USD MILLION)
                                      TABLE 183 INDIA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 184 INDIA: URINALYSIS TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 185 INDIA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 186 INDIA: URINALYSIS TEST MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 187 REST OF ASIA PACIFIC: URINALYSIS MARKET REPORT, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 188 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 189 REST OF ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 190 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 191 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 192 REST OF ASIA PACIFIC: URINALYSIS MARKET DEMAND, BY TEST TYPE, 2020–2027 (USD MILLION)
                        TABLE 193 REST OF ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 194 REST OF ASIA PACIFIC: URINALYSIS MARKET DEMAND, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 195 REST OF ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 196 REST OF ASIA PACIFIC: URINALYSIS MARKET DEMAND, BY END USER, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA 
             TABLE 197 LATIN AMERICA: URINALYSIS MARKET DEMAND, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 198 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 199 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 200 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 201 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 202 LATIN AMERICA: URINALYSIS MARKET DEMAND, BY TEST TYPE, 2020–2027 (USD MILLION)
             TABLE 203 LATIN AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 204 LATIN AMERICA: URINALYSIS MARKET ANALYSIS, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 205 LATIN AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 206 LATIN AMERICA: URINALYSIS MARKET ANALYSIS, BY END USER, 2020–2027 (USD MILLION)
             10.5.1 RECESSION IMPACT
     10.6 MIDDLE EAST & AFRICA 
             TABLE 207 MIDDLE EAST & AFRICA: URINALYSIS MARKET ANALYSIS, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 208 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 209 MIDDLE EAST & AFRICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 210 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 211 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 212 MIDDLE EAST & AFRICA: URINALYSIS MARKET ANALYSIS, BY TEST TYPE, 2020–2027 (USD MILLION)
             TABLE 213 MIDDLE EAST & AFRICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 214 MIDDLE EAST & AFRICA: URINALYSIS MARKET ANALYSIS, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 215 MIDDLE EAST & AFRICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 216 MIDDLE EAST & AFRICA: URINALYSIS MARKET RESEARCH, BY END USER, 2020–2027 (USD MILLION)
             10.6.1 RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 166)
     11.1 OVERVIEW 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 
             11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
                        TABLE 217 STRATEGIES DEPLOYED BY KEY COMPANIES
     11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 22 REVENUE SHARE ANALYSIS OF TOP PLAYERS
     11.4 MARKET SHARE ANALYSIS 
             11.4.1 URINALYSIS MARKET RESEARCH
                        FIGURE 23 URINALYSIS MARKET SHARE, BY KEY PLAYER (2021)
                        TABLE 218 URINALYSIS MARKET RESEARCH: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION QUADRANT 
             11.5.1 LIST OF EVALUATED VENDORS
             11.5.2 STARS
             11.5.3 EMERGING LEADERS
             11.5.4 PERVASIVE PLAYERS
             11.5.5 PARTICIPANTS
                        FIGURE 24 URINALYSIS MARKET RESEARCH: COMPETITIVE LEADERSHIP MAPPING, 2021
     11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021) 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 25 URINALYSIS MARKET RESEARCH: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
     11.7 COMPETITIVE BENCHMARKING 
             11.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
                        FIGURE 26 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF LEADING PLAYERS
                        TABLE 219 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
                        TABLE 220 COMPANY PRODUCT FOOTPRINT
                        TABLE 221 COMPANY REGIONAL FOOTPRINT
     11.8 COMPETITIVE SCENARIO 
             11.8.1 PRODUCT LAUNCHES AND APPROVALS
                        TABLE 222 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
             11.8.2 DEALS
                        TABLE 223 KEY DEALS
 
12 COMPANY PROFILES (Page No. - 177)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS 
             12.1.1 SIEMENS HEALTHINEERS AG
                        TABLE 224 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
                        FIGURE 27 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
             12.1.2 F. HOFFMANN-LA ROCHE LTD.
                        TABLE 225 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
                        FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
             12.1.3 CARDINAL HEALTH, INC.
                        TABLE 226 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                        FIGURE 29 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
             12.1.4 ABBOTT LABORATORIES
                        TABLE 227 ABBOTT LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
             12.1.5 DANAHER CORPORATION
                        TABLE 228 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.6 SYSMEX CORPORATION
                        TABLE 229 SYSMEX CORPORATION: BUSINESS OVERVIEW
                        FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.7 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 230 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
             12.1.8 QUIDEL CORPORATION
                        TABLE 231 QUIDEL CORPORATION: BUSINESS OVERVIEW
                        FIGURE 34 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.9 BECTON, DICKINSON AND COMPANY
                        TABLE 232 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
             12.1.10 BIO-RAD LABORATORIES, INC.
                        TABLE 233 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
             12.1.11 EKF DIAGNOSTICS
                        TABLE 234 EKF DIAGNOSTICS: BUSINESS OVERVIEW
                        FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021)
     12.2 OTHER PLAYERS 
             12.2.1 ARKRAY, INC.
                        TABLE 235 ARKRAY, INC.: COMPANY OVERVIEW
             12.2.2 ACON LABORATORIES, INC.
                        TABLE 236 ACON LABORATORIES, INC.: COMPANY OVERVIEW
             12.2.3 77 ELEKTRONIKA KFT.
                        TABLE 237 77 ELEKTRONIKA KFT.: COMPANY OVERVIEW
             12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
                        TABLE 238 URIT MEDICAL ELECTRONIC GROUP CO., LTD.: COMPANY OVERVIEW
             12.2.5 DIRUI INDUSTRIAL CO., LTD.
                        TABLE 239 DIRUI INDUSTRIAL CO., LTD.: COMPANY OVERVIEW
             12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
                        TABLE 240 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
             12.2.7 BIOBASE GROUP
                        TABLE 241 BIOBASE GROUP: COMPANY OVERVIEW
             12.2.8 ERBA MANNHEIM
                        TABLE 242 ERBA MANNHEIM: COMPANY OVERVIEW
             12.2.9 ALPHATEC SCIENTIFIC
                        TABLE 243 ALPHATEC SCIENTIFIC: COMPANY OVERVIEW
             12.2.10 TECO DIAGNOSTICS
                        TABLE 244 TECO DIAGNOSTICS: COMPANY OVERVIEW
             12.2.11 ANALYTICON BIOTECHNOLOGIES AG
                        TABLE 245 ANALYTICON BIOTECHNOLOGIES AG: COMPANY OVERVIEW
             12.2.12 BIOWAY BIOTECHNOLOGY
                        TABLE 246 BIOWAY BIOTECHNOLOGY: COMPANY OVERVIEW
             12.2.13 HIGH TECHNOLOGY, INC.
                        TABLE 247 HIGH TECHNOLOGY, INC.: COMPANY OVERVIEW
             12.2.14 AGAPPE DIAGNOSTICS
                        TABLE 248 AGAPPE DIAGNOSTICS: COMPANY OVERVIEW
             12.2.15 GENRUI BIOTECH, INC.
                        TABLE 249 GENRUI BIOTECH, INC.: COMPANY OVERVIEW
             12.2.16 SPINREACT S.A.
                        TABLE 250 SPINREACT S.A.: COMPANY OVERVIEW
             12.2.17 DIALAB GMBH
                        TABLE 251 DIALAB GMBH: COMPANY OVERVIEW
             12.2.18 QUANTIMETRIX CORPORATION
                        TABLE 252 QUANTIMETRIX CORPORATION: COMPANY OVERVIEW
             12.2.19 BIOCARE CORPORATION
                        TABLE 253 BIOCARE CORPORATION: COMPANY OVERVIEW
             12.2.20 RANDOX LABORATORIES LTD.
                        TABLE 254 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
             12.2.21 PZ CORMAY SA
                        TABLE 255 PZ CORMAY SA: COMPANY OVERVIEW
             12.2.22 YD DIAGNOSTICS
                        TABLE 256 YD DIAGNOSTICS: COMPANY OVERVIEW
             12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD.
                        TABLE 257 CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 223)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the urinalysis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Urinalysis Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the urinalysis market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the urinalysis market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Urinalysis Market Size

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the urinalysis market by product, test type, end user and region.
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities and challenges).
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa,
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To track and analyze company developments such as product launch, product approval, agreement, partnership in the urinalysis market.
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Urinalysis market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa.

Company profiles

  • Product portfolio matrix for leading market players.

Top 10 companies in urine test market

The urine test market includes a range of companies involved in developing, manufacturing, and distributing urine testing products. Here are ten companies that are major players in the urine test market

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Beckman Coulter
  • bioMérieux SA
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • BD (Becton, Dickinson and Company)
  • Danaher Corporation
  • Bio-Rad Laboratories

It's worth noting that this is not an exhaustive list, and there are many other companies involved in the urine test market as well. Additionally, some of these companies may be more focused on other aspects of diagnostic testing beyond urine tests.

Newer urine test applications targeted by Abbott Laboratories in future

Abbott Laboratories has been actively developing and marketing innovative urine testing solutions that can be used for a wide range of applications. Some of the newer applications that Abbott is targeting with its urine testing products include

Chronic kidney disease (CKD): Abbott's iSTAT Alinity platform, which includes the iChem Velocity urine analyzer, is designed to provide rapid and accurate results for a range of urine tests, including those used in the diagnosis and management of CKD.

Pregnancy testing: Abbott's Clearview hCG pregnancy test is a rapid, one-step urine test that detects the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy.

Infectious disease testing: Abbott's Alere i platform, which includes the Alere iCup urine drug testing system, can be used to detect the presence of infectious agents such as influenza and respiratory syncytial virus (RSV).

Drug testing: Abbott's Alere iCup urine drug testing system is used to screen for the presence of a range of drugs, including opioids, amphetamines, and benzodiazepines.

Sports medicine: Abbott's iSTAT Alinity platform and other urine testing products can be used to monitor athletes for signs of dehydration, electrolyte imbalances, and other conditions that can impact performance and health.

Overall, Abbott Laboratories is committed to developing and marketing innovative urine testing solutions that can be used for a wide range of applications, from disease diagnosis and management to sports medicine and drug testing. As the healthcare industry continues to evolve, it is likely that Abbott will continue to target new and emerging applications for its urine testing products.

Industries getting impacted in the future by urine test market

The urine test market is expected to impact a wide range of industries in the future, as urine testing is used in many different settings for a variety of applications. Here are a few industries that may be particularly impacted by the urine test market in the future

Healthcare: The healthcare industry is expected to be one of the primary beneficiaries of urine testing, as urine tests are used in the diagnosis and management of a wide range of conditions, from infectious diseases and pregnancy to kidney disease and drug abuse.

Pharmaceuticals: The pharmaceutical industry may also be heavily impacted by urine testing, as the data generated by these tests can be used to develop and test new drugs and therapies. For example, urine tests may be used to monitor the safety and efficacy of new drugs in clinical trials.

Sports: The sports industry is increasingly using urine testing to monitor athletes for signs of dehydration, electrolyte imbalances, and other conditions that can impact performance and health.

Employment: Many employers use urine testing to screen job candidates for drug use and to ensure a safe and drug-free workplace. As the labor market becomes more competitive, employers may increasingly rely on urine testing to make informed hiring decisions.

Forensics: Urine testing is also used in forensics and criminal investigations, as urine can be used to identify drugs, toxins, and other substances in the body.

Overall, the urine test market is expected to impact a wide range of industries in the future, as the technology and applications of urine testing continue to evolve and expand.

Top use cases including existing and futuristic for urine test market

The urine test market has a wide range of use cases, both existing and futuristic. Here are some of the top use cases for urine testing

Disease diagnosis and management: Urine tests are commonly used in the diagnosis and management of a wide range of diseases, including kidney disease, diabetes, liver disease, and urinary tract infections.

Pregnancy testing: Urine tests are often used to detect the presence of human chorionic gonadotropin (hCG), a hormone produced during pregnancy, and to monitor pregnancy-related conditions such as preeclampsia.

Drug testing: Urine tests are used to screen for the presence of a wide range of drugs, including opioids, amphetamines, and benzodiazepines. These tests are commonly used in workplace drug testing programs, as well as in drug rehabilitation programs.

Sports medicine: Urine tests are increasingly used in sports medicine to monitor athletes for signs of dehydration, electrolyte imbalances, and other conditions that can impact performance and health.

Infectious disease testing: Urine tests are used to detect the presence of infectious agents such as influenza and respiratory syncytial virus (RSV).

Cancer screening: Researchers are exploring the potential of urine tests to detect the presence of cancer cells, which could allow for earlier and more accurate cancer diagnosis.

Personalized medicine: Researchers are also exploring the potential of urine tests to provide personalized medical insights based on an individual's unique metabolic profile.

Overall, the urine test market has a wide range of existing and potential use cases, and is expected to continue to grow and evolve as new technologies and applications are developed.

Hypothetic challenges of urine test business in future

While the urine test market has a lot of potential for growth, there are also several hypothetical challenges that could impact the industry in the future. Here are a few examples

Increasing competition: As the urine test market continues to grow, we can expect to see more companies entering the space, which could lead to increased competition and pricing pressure.

Evolving regulations: The urine test market is subject to a range of regulations, both in terms of manufacturing and in terms of how tests are used and interpreted. As regulations evolve, companies may need to adapt their products and processes to remain compliant.

Evolving technology: Advances in technology could change the way urine tests are developed, manufactured, and interpreted. Companies that fail to keep up with these changes may struggle to compete.

Supply chain disruptions: The global COVID-19 pandemic highlighted the fragility of supply chains, and disruptions to the supply of key materials and components could impact the urine test market in the future.

Privacy concerns: As the amount of data generated by urine tests grows, there could be increasing concerns around patient privacy and data security.

It's important to note that these are hypothetical challenges, and the urine test market may not be impacted by all or any of these factors. Additionally, there may be other challenges that emerge in the future that are not currently foreseeable.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 3259
Published ON
Feb, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Urinalysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback